Conversion of T-Effector Cells to Immunosuppressive T-Regulatory-like Cells By CRISPR/Cas9-Mediated Integration of a FOXP3 Transgene

Yuchi Honaker, David J. Rawlings(Center for Infectious Disease Research), Karen Sommer, Logan Fisher, Andrew M. Scharenberg(CTI BioPharma (Italy)), Troy R. Torgerson(Allen Institute for Immunology), Yufei Xiang(Central South University)
Blood
November 29, 2018
Cited by 4


Related Papers